Jasper Therapeutics Stock Price on February 20, 2024
| JSPR Stock | USD 22.81 0.43 1.85% |
Below is the normalized historical share price chart for Jasper Therapeutics extending back to January 10, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Jasper Therapeutics stands at 22.81, as last reported on the 1st of December, with the highest price reaching 24.27 and the lowest price hitting 22.70 during the day.
If you're considering investing in Jasper Stock, it is important to understand the factors that can impact its price. Jasper Therapeutics appears to be slightly risky, given 3 months investment horizon. Jasper Therapeutics holds Efficiency (Sharpe) Ratio of 0.0811, which attests that the entity had a 0.0811% return per unit of risk over the last 3 months. We have found thirty technical indicators for Jasper Therapeutics, which you can use to evaluate the volatility of the firm. Please utilize Jasper Therapeutics' Market Risk Adjusted Performance of 0.1191, downside deviation of 5.09, and Risk Adjusted Performance of 0.0587 to validate if our risk estimates are consistent with your expectations.
At this time, Jasper Therapeutics' Total Stockholder Equity is relatively stable compared to the past year. As of 12/01/2024, Other Stockholder Equity is likely to grow to about 260.4 M, while Liabilities And Stockholders Equity is likely to drop slightly above 62.3 M. . At this time, Jasper Therapeutics' Price Book Value Ratio is relatively stable compared to the past year. As of 12/01/2024, Price Earnings To Growth Ratio is likely to grow to 0.20, while Price To Operating Cash Flows Ratio is likely to drop (1.66). Jasper Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 24th of September 2021 | 200 Day MA 21.9208 | 50 Day MA 20.2475 | Beta 2.199 |
Jasper |
Sharpe Ratio = 0.0811
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | JSPR | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.69 actual daily | 41 59% of assets are more volatile |
Expected Return
| 0.38 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Jasper Therapeutics is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Jasper Therapeutics by adding it to a well-diversified portfolio.
Price Book 4.0892 | Book Value 5.578 | Enterprise Value 251.7 M | Enterprise Value Ebitda (3.42) | Shares Float 9.3 M |
Jasper Therapeutics Main Headline on 20th of February 2024
Acquisition by Mahal Jeetinder Singh of 40000 shares of Jasp... by Mahal Jeetinder Singh
Filed transaction by Jasper Therapeutics Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Jasper Therapeutics Valuation on February 20, 2024
It is possible to determine the worth of Jasper Therapeutics on a given historical date. On February 20, 2024 Jasper was worth 19.32 at the beginning of the trading date compared to the closed value of 19.44. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Jasper Therapeutics stock. Still, in general, we apply an absolute valuation method to find Jasper Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Jasper Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Jasper Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 17.91 | 19.76 | 17.91 | 18.94 | 100,916 | |
02/20/2024 | 19.32 | 19.50 | 18.55 | 19.44 | 61,789 |
| 19.18 | 19.59 | 18.86 | 18.91 | 44,333 |
| Backtest Jasper Therapeutics | | | Jasper Therapeutics History | | | Jasper Therapeutics Valuation | Previous | Next |
Jasper Therapeutics Trading Date Momentum on February 20, 2024
| On February 21 2024 Jasper Therapeutics was traded for 18.91 at the closing time. The top price for the day was 19.59 and the lowest listed price was 18.86 . The trading volume for the day was 44.3 K. The trading history from February 21, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 2.73% . The trading delta at closing time against the current closing price is 10.29% . |
Jasper Therapeutics Fundamentals Correlations and Trends
By evaluating Jasper Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Jasper Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Jasper financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Jasper Therapeutics Stock history
Jasper Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Jasper is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Jasper Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Jasper Therapeutics stock prices may prove useful in developing a viable investing in Jasper Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 10.4 M | 11 M | |
| Net Loss | -33.9 M | -32.2 M |
Jasper Therapeutics Quarterly Net Working Capital |
|
Jasper Therapeutics Stock Technical Analysis
Jasper Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Jasper Therapeutics Period Price Range
Low | December 1, 2024
| High |
0.00 | 0.00 |
Jasper Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Jasper Therapeutics December 1, 2024 Market Strength
Market strength indicators help investors to evaluate how Jasper Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Jasper Therapeutics shares will generate the highest return on investment. By undertsting and applying Jasper Therapeutics stock market strength indicators, traders can identify Jasper Therapeutics entry and exit signals to maximize returns
Jasper Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Jasper Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Jasper Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Jasper to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0587 | |||
| Jensen Alpha | (0.05) | |||
| Total Risk Alpha | (0.51) | |||
| Sortino Ratio | 0.0371 | |||
| Treynor Ratio | 0.1091 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Jasper Stock Analysis
When running Jasper Therapeutics' price analysis, check to measure Jasper Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jasper Therapeutics is operating at the current time. Most of Jasper Therapeutics' value examination focuses on studying past and present price action to predict the probability of Jasper Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jasper Therapeutics' price. Additionally, you may evaluate how the addition of Jasper Therapeutics to your portfolios can decrease your overall portfolio volatility.